Cihan Tastan
Ueskuedar, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
CRISPR-Cas9-Mediated Targeting of Multidrug Resistance Genes in Methicillin-Resistant Staphylococcus aureus.
Journal: The CRISPR journal
Published: November 08, 2024
Unveiling Off-Target Mutations in CRISPR Guide RNAs: Implications for Gene Region Specificity.
Journal: The CRISPR journal
Published: June 26, 2024
Comparison of strain specific pathogenicity of Herpes Simplex Virus Type 1 by high-throughput sequencing.
Journal: Journal of virological methods
Published: April 24, 2024
CRISPR.BOT an autonomous platform for streamlined genetic engineering and molecular biology applications.
Journal: Scientific reports
Published: February 26, 2024
In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: April 06, 2023
CAR-T Cells with Phytohemagglutinin (PHA) Provide Anti-Cancer Capacity with Better Proliferation, Rejuvenated Effector Memory, and Reduced Exhausted T Cell Frequencies.
Journal: Vaccines
Published: November 22, 2022
Lentiviral Micro-dystrophin Gene Treatment into Late-stage mdx Mice for Duchenne Muscular Dystrophy Disease.
Journal: Current gene therapy
Published: August 01, 2022
Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: July 18, 2022
Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice.
Journal: Scientific reports
Published: March 21, 2021
Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates.
Journal: Scientific reports
Published: October 06, 2020
Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: August 06, 2020
Last Updated: 09/26/2026